EL Mayer

SABRE-B: an evaluation of paclitaxel and bevacizumab with or without sunitinib as first-line treatment of metastatic breast cancer

EL Mayer, S. Dhakil, Taral Patel et al. · Annals of Oncology · 2010 · 50 citations · Full text

Metastatic Breast Cancer, Oncology, Breast Oncology +7

Abstract PD1-6: A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus (an mTOR inhibitor) in patients with stage II/III triple-negative breast cancer (TNBC)

IA Mayer, Bojana Jovanović, V Abramson et al. · Cancer Research · 2013 · 14 citations

Surgical Oncology, Breast Oncology, Cancer Management +17

Abstract P6-11-06: A phase Ib study of LCL161, an oral inhibitor of apoptosis (IAP) antagonist, in combination with weekly paclitaxel in patients with advanced solid tumors

Rodrigo Dienstmann, Laura Vidal, EC Dees et al. · Cancer Research · 2012 · 13 citations

Phase Ib Study, Tumor Biology, Impaired Apoptosis +15

Abstract OT3-05-11: Palbociclib after CDK inhibitor and endocrine therapy (PACE): A randomized phase II study of fulvestrant versus palbociclib plus fulvestrant, with and without avelumab, for CDK inhibitor pre-treated HR+/HER2- metastatic breast cancer

EL Mayer, SA Wander, MM Regan et al. · Cancer Research · 2018 · 10 citations

Metastatic Breast Cancer, Oncology, Breast Oncology +15